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SI Appendix 
 
Materials and Methods 
 
Synthesis of DSS-DAK-PEG-OPSS. NHS-PEG-OPSS (5kDa, Laysan Bio) was 
dissolved in dry DCM at 10 mg/mL. To this was added both 20x molar excess 
triethylamine (TEA) and 20x DAK (2,2-bis(aminoethoxy)propane, Sigma Aldrich). The 
solution was stirred for 5 hrs under argon at room temperature. N-(2-
aminoethyl)aminomethyl polystyrene beads (NH2-bead, EMD Millipore) presoaked in 
dry DCM were added at 10x molar excess to DAK and stirred for one hour under the 
same conditions. The solution was filtered then precipitated by addition of diethyl ether. 
After sitting at room temperature for 15 min, the precipitate was isolated by 
centrifugation at 3220 g for 15 min. The solid was washed with ether and collected by 
centrifugation twice more. The product was dried under vacuum to yield a dense, white 
solid. The resulting DAK-PEG-OPSS was dissolved in dry DCM at 10 mg/mL. 
Disuccinimidyl suberate (DSS, Pierce) and TEA were added at 10x molar excess. The 
reaction was stirred under argon at room temperature for 90 min. The product was 
precipitated by addition of diethyl ether. After sitting at room temperature for 30 min, the 
precipitate was isolated by centrifugation at 3220 g for 15 min. The solid was washed 
with ether and collected by centrifugation twice more. It was dried under vacuum to yield 
a dense, white solid. 
 
Preparation of Ligand-DAK-PEG-OPSS: Human holo-Tf (Sigma) or R17217 anti-TfR 
Ab (Biolegend) was dissolved in 100 mM NaHCO3 pH 8.5 at 10 mg/mL. DSS-DAK-
PEG-OPSS (2.5x molar excess) was dissolved in DMSO at 30 mg/mL and added to the 
ligand. The solution reacted at room temperature for 60 min with light agitation. Excess 
PEG was removed and the reaction was quenched by centrifugation through a 50 kDa 
MWCO spin filter (EMD Millipore) at 14000 g for 5 min. The retentate was washed with 
10 mM NaH2PO4 pH 8.0. This process was repeated for a total of three washes. 
Conjugation was verified by MALDI-TOF (Voyager DE Pro, PerSeptive Biosystems) 
using a sinapinic acid matrix. Multi-PEGylated species were removed from the mixture 
by hydrophobic interaction chromatography (HIC) on a AKTA Prime Plus FPLC System 
(GE Healthcare, 5mL HiTrap Phenyl column) using a high salt buffer of 1 M ammonium 
sulfate with 50 mM sodium phosphate pH 7.5 and an elution buffer consisting of the 
latter salt only (Fig. S1B,D). Iron citrate (2.5x molar excess) in 100 mM NaHCO3 pH 8.5 
was added to the Tf-DAK-PEG conjugate following HIC. Excess iron was removed 
through centrifugation using a 50 kDa MWCO spin filter, then the conjugate was washed 
with 10 mM NaH2PO4 pH 8.0. This process was repeated for a total of five washes. The 
amount of iron loaded to the Tf was measured by UV-VIS using the ratio of A465/A280. 
This value was compared to the A465/A280 ratio of the non-processed holo-Tf. A value 
≥80% of the unprocessed ratio indicated adequate iron reloading. 
The amount of mono-PEGylated ligand remaining in the separated mixture was 
determined by a dipyridyl disulfide cleavage assay. The Ligand-DAK-PEG mixture was 
diluted in 10 mM NaH2PO4 pH 8.0 with 1 mM ethylenediaminetetraacetic acid (EDTA) 
and the absorbance at 343 nm was recorded. Dithiothreitol (DTT) was added to the 
protein solution to give a final concentration of 1.5 mg/mL DTT. After sitting for 15 min 
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at room temperature, the absorbance at 343 nm was recorded again. The difference in 
A343 was calculated and compared to a standard curve prepared from pure, noncleavable, 
mono-PEGylated Tf-PEG-OPSS or Ab-PEG-OPSS as necessary. The calculated OPSS 
concentration was used to determine the concentration of Ligand-DAK-PEG-OPSS in the 
mixture. 
 
pH-Dependent Stability of Tf-DAK-PEG-OPSS: Purified Tf-DAK-PEG-OPSS was 
prepared at approximately 5 mg/mL in either 10 mM NaH2PO4 pH 8.0 or 100 mM 
NaOAc pH 5.5 at 37°C. Aliquots were removed at various time points and diluted 1:10 in 
10 mM NaH2PO4 pH 8.0 and frozen on CO2(s). After all aliquots were taken, samples 
were thawed and analyzed simultaneously by MALDI-TOF as described above.  
 
Preparation of Ligand-PEG-OPSS: Either human holo-Tf or R17217 Ab was dissolved 
in 100 mM NaHCO3 pH 8.5 at 0.5 mg/mL. NHS-PEG-OPSS (5 kDa, Laysan Bio) was 
added at 2.5x molar excess. The reaction sat at room temperature for 60mins under light 
rocking. Excess PEG was removed and the reaction was quenched by centrifugation 
through a 50 kDa MWCO spin filter at 14000 g for 5 mins. The retentate was washed 
with 10 mM NaH2PO4 pH 8.0 twice more. Conjugation was verified by MALDI-TOF 
using a sinapinic acid matrix. For Tf-PEG-OPSS, the monoPEGylated fraction was 
isolated by HPLC (Agilent 1200 series) using two TOSOH TSK gel G3000swxl columns 
in series followed by HIC and iron reloading as described previously (Fig. S1A). The 
monoPEGylated Ab-PEG-OPSS was isolated solely through HIC (Fig. S1C). Both 
conjugates were stored in 10 mM NaH2PO4 pH 8.0 at 4°C until use. 
 
Preparation of Nanoparticles: Either Ligand-DAK-PEG-OPSS or Ligand-PEG-OPSS 
was added to 50 nm gold nanoparticles (BBI International) at the appropriate molar 
excess (e.g. nanoparticles dosed with 20x molar excess Tf-PEG produced 20 Tf/NP). The 
solution was stirred vigorously for 60 min then methoxy-PEG-thiol (mPEG-SH) (5kDa, 
Laysan Bio) was added at 10,000x molar excess and stirred for another 30 min. The 
nanoparticles were collected by centrifugation at 20,000 g for 10 min, washed with dH2O 
and sonicated for 5 min. This process was repeated twice more to give three total washes. 
After the final centrifugation, the particles were resuspended in 10 mM NaH2PO4 pH 8.0. 
To prepare untargeted nanoparticles (mPEG), only mPEG-SH was added to 50 nm gold 
cores for 60 min with vigorous stirring. The nanoparticles were purified as described 
above. 
 
Nanoparticle Characterization: Nanoparticles were characterized using a Brookhaven 
Instruments ZetaPALS. Nanoparticles were diluted in PBS and hydrodynamic diameter 
was measured using dynamic light scattering (DLS). Zeta potential was measured in 1 
mM KCl (pH 7.0) using a target residual of 0.02. Five runs were performed for both the 
nanoparticle diameter and zeta potential measurements. 
 
Nanoparticle Binding Assay: Neuro2A cells (ATCC) were grown at 37°C, 5% CO2 in 
DMEM+10% FBS with penicillin/streptomycin. Cells were washed with PBS and 
removed using a cell scraper. After centrifugation at 300 g for 3 min, the cells were fixed 
using BD Cytofix (BD Biosciences) for 20 min at 4°C. The cells were then washed and 
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resuspended in PBS + 4% BSA. Increasing concentrations of nanoparticles were added to 
1x106 cells at 5x106 cells/mL and sat at RT with light agitation every 15 min to prevent 
cells from settling. After 90 min, the cells were added to 12 mL PBS and centrifuged at 
300 g for 3 min. The cells were resuspended in 12 mL fresh PBS and centrifuged again. 
This washing procedure was performed for a total of three times. Finally, the cell solution 
was added to a 96 well plate, silver enhancement solution (Ted Pella) was added and 
fluorescence read (310 nm excitation, 400 nm emission) using a plate reader (Tecan, 
infinite M200). Data were fit to a Langmuir binding isotherm using Matlab, and KD and 
Bmax were calculated. 
To measure avidity after exposure to mild acid, 200Tf-C and 10Ab-C 
formulations were incubated for four hours at 37°C in 100 mM NaOAc, pH 5.5. The 
nanoparticles were collected by centrifugation at 20,000 g for 10 min and washed in 
dH2O twice. After the final wash, they were resuspended in PBS + 4% BSA, added to 
Neuro2A cells and analyzed as described above. 
 
Nanoparticle Transcytosis Across bEnd.3-coated Transwells: bEnd.3 cells (ATCC) 
were grown in 37°C, 5% CO2 in DMEM+10% FBS with penicillin/streptomycin. The 
cells were seeded on 12 mm polyester-coated transwell supports (Corning) at 82,500 
cells/well. Media was replaced in the apical and basal wells every two-three days. 
Transepithelial electrical resistance (TEER) was measured in an Endohm chamber and 
using an EVOM resistance meter (World Precision Instruments). Once TEER had 
reached ≥30 Ohms*cm2, transcytosis experiments were performed. Prior to introduction 
of nanoparticles, both compartments of the transwell were washed with serum-free 
DMEM and allowed to equilibrate for 1hr. Nanoparticles were added at 1x1010 
particles/well to the apical well. At various time points, the entire volume was removed 
from the basal well and replaced with fresh media. The aliquot was diluted in water and 
measured for gold content using an HP 7500 ICP-MS (Agilent). A Babington type 
nebulizer in a Pyrex Scott-type spray chamber was used for nebulization at a carrier flow 
rate of 1.3 L/min of argon. The argon plasma power was 1200 W with a flow of 15 L/min 
and an auxiliary flow of 1.1 L/min. A calibration curve of known concentrations of non-
targeted AuNPs (mPEG) was prepared and used to determine gold concentration in the 
aliquots. Reported values are the average of three wells per group, except for the 20Tf-C 
group which contains four measurements. The error shown is standard error of the mean. 
Pairwise group comparisons testing for statistically significant differences were 
performed using a two-sample t-test in Matlab. 
For the Tf-competition assay, both compartments of the transwell were washed 
and incubated in DMEM + 2.5 mg/mL hTf for 1 hr prior to nanoparticle introduction. 
The assay was performed as described above using DMEM + 2.5 mg/mL Tf as the 
replacement media. Three wells were performed for each nanoparticle formulation in the 
competition assay.  
To determine intracellular gold content, the transwells were removed from the 
basal compartment after 8 hrs and the apical volume was removed. Cells were washed 8 
times with 200 μL PBS to clear unbound nanoparticles then lysed by addition of 100 μL 
RIPA buffer (Pierce) to each transwell. The lysate was centrifuged at 14000 g for 5 min 
to pellet cell debris and the supernatant prepared for ICP-MS as described above. The 
lysates were quantitated with an Agilent 8800 triple quadrupole (ICP-QQQ) ICP-MS 
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using a MicroMist nebulizer and Scott-type spray chamber with a carrier gas flow rate of 
1.05 L/min of argon. The plasma power was 1600 W with a flow of 15 L/min. 
 
Animal Injections and Tissue Processing: All animals were treated according to the 
NIH Guidelines for Animal Care and Use as approved by the Caltech Institutional 
Animal Care and Use Committee. Three female BALB/c mice (Jackson Laboratory) were 
each injected with 4.5x1011 nanoparticles via lateral tail vein for all nanoparticle 
formulations. The mice were euthanized by CO2 asphyxiation after 12 hrs. The brains 
were resected and bisected with a manual mid-sagittal cut before fixing both hemispheres 
overnight in 10% neutral buffered formalin (Sigma). Individual hemispheres were 
dehydrated in increasing concentrations of ethanol (3 x 30 min each for 50, 70, 95 and 
100% EtOH), followed by xylenes (3 x 30 min) and 50:50 xylene:paraffin mixture (1 x 
30 min). The tissues were then incubated in molten paraffin (3 x 1 hr) at 60°C. The brains 
were placed in a paraffin mold and stored at 4°C until sectioning. A Leica 1512 
microtome was used to cut 5 μm sections.  
 
Silver Enhancement Staining of Mouse Brains: All glassware used was washed with 
Farmer’s Solution (9 parts 10% sodium thiosulfate and 1 part 10% potassium 
ferricyanide) for 20 min prior to tissue processing to reduce non-specific silver staining. 
Paraffin-embedded sections were deparaffinized in xylenes, rehydrated using decreasing 
concentrations of ethanol and washed in pure water (3 x 1min). Silver enhancement 
solution (Ted Pella) was added to the sections for 20 min. The stained sections were 
immediately placed in water for 5 min followed by counterstaining with haematoxylin for 
2 min. They were then dehydrated with increasing concentration of ethanol and xylenes 
and mounted with Permount (Fisher). 
 
Image Analysis, Nanoparticle Counting and Statistics: Processed sections were 
imaged using an Olympus IX50 microscope with a 40x objective and QCapture Pro 6 
imaging software (QImaging). Images were acquired from sections near the mid-sagittal 
plane. A total of 40 images were acquired from each tissue section, consisting of ten 
images taken from rostral, ventral, dorsal and cerebellar regions of the brain. For each 
region, an arbitrary starting point was chosen and imaged. Subsequent images were 
obtained at consistent, transverse intervals along the entire length of the region. 
Nanoparticles observed distinctly outside the margins of blood vessels were counted as 
parenchymal particles. All image acquisition and particle counting steps were performed 
blindly. A brain containing no AuNP’s (blank) was processed and imaged simultaneously 
with the experimental groups. Instances of nanoparticle-like signal  (Fig. S7, arrows) 
were observed in the blank brain and determined to be non-specific silver stain 
deposition. The median value of these phenomena was subtracted from all the 
experimental groups. Large, amorphous areas of silver stain (Fig. S7, inset) were also 
observed in both the blank and experimental groups and concluded to be non-specific 
silver deposition. These instances were not counted and were excluded from the 
quantitative analysis. Pairwise group comparisons testing for statistically significant 
differences were performed using the Wilcoxon rank-sum test in Matlab (Table S2). 
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Supplemental Figures 
 
 
 
Fig. S1. MALDI-TOF spectra of purified conjugates. (A) Mono-PEGylated Tf-PEG-
OPSS. (B) Mixture of unreacted Tf (79kDa) and mono-PEGylated Tf-DAK-PEG-OPSS 
(84kDa). (C) Mono-PEGylated R17217-PEG-OPSS. (D) Mixture of unreacted Ab 
(153kDa) and mono-PEGylated R17217-DAK-PEG-OPSS (158kDa).  
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Fig. S2. Tf-DAK-PEG-OPSS pH-dependent stability. (A) The conjugate rapidly cleaves 
to native Tf (peak 1, 79kDa) from a mixture of monoPEGylated (peak 2, 84kDa) and 
diPEGylated (peak 3, 89kDa) conjugate over the course of 120 min when placed in pH 
5.5 buffer at 37°C. (B) The same conjugate as in (A) placed at pH 8, 37°C shows much 
slower degradation. At two hours (green trace) the amount of monoPEGylated Tf-DAK-
PEG (peak 2) is virtually unchanged and the conjugate is still present 24 hrs later (red 
trace).    
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Fig. S3. Nanoparticle binding avidity to Neuro2A cells. Binding data for (A) Tf-N, (B) 
Tf-C, (C) Ab-N and (D) Ab-C formulations are shown. Model curves are based on the 
Langmuir binding isotherm with Kd and Bmax determined by fitting the data (Matlab). 
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Fig. S4. Tf-containing nanoparticles show decreased ability to cross bEnd.3 transwells in 
the presence of hTf. Nanoparticles were added to apical wells in either serum-free 
DMEM (black bars) or in the presence of 2.5 mg/mL hTf (white bars). Total 
nanoparticles reaching the basal well at 8 hrs was measured by ICP-MS. Error bars 
indicate SE (n = 3 for each Tf-competition group). 
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Fig. S5. bEnd.3 transwell crossing over time for Ab-containing nanoparticles. Data 
shown are an average of three transwells per group. Error shown is SE.  
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Fig. S6. Intracellular gold content for bEnd.3 cells exposed to high avidity formulations. 
After 8 hrs, cells exposed to high avidity formulations were lysed and intracellular gold 
content determined. Data shown are an average of three transwells. Error bars indicate 
SE. * = p<0.05 
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Fig. S7. Silver staining of brain containing no gold nanoparticles. (A) Blood vessels are 
absent of silver stain. Rare occurrences of nanoparticle-like signal (arrows) were present 
in the blank brain. These instances were counted and the median value subtracted from 
the experimental groups. (B) Larger, amorphous silver deposition was observed in all 
samples, including the blank brain, and determined to be non-specific silver stain. These 
instances were neither counted nor included in the quantitative analysis.   
! 12 
 
 
Fig. S8. Images from silver-stained brains of mPEG, 20Tf-N and 200Tf-N formulations. 
Left column contains full sized image and right column contains area highlighted in black 
box. Arrows indicate amorphous silver stain determined to be non-specific silver 
deposition and were not included in the quantitative analysis. 
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Fig. S9. Images from silver-stained brains of 20Tf-C, 120Tf-C and 200Tf-C 
formulations. Left column contains full sized image and right column contains area 
highlighted in black box. Arrows indicate amorphous silver stain determined to be non-
specific silver deposition and were not included in the quantitative analysis. 
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Fig. S10. Images from silver-stained brains of 2Ab-N and 10Ab-N formulations. Left 
column contains full sized image and right column contains area highlighted in black 
box. Arrows indicate amorphous silver stain determined to be non-specific silver 
deposition and were not included in the quantitative analysis. 
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Fig. S11. Images from silver-stained brains of 2Ab-C and 10Ab-C formulations. Left 
column contains full sized image and right column contains area highlighted in black 
box. Arrows indicate amorphous silver stain determined to be non-specific silver 
deposition and were not included in the quantitative analysis. 
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Supplemental Tables 
 
 
 
Table S1. Percentage of total nanoparticle crossing bEnd.3-coated transwells over time 
per formulation for Tf-containing nanoparticles. All Tf-C formulations cross rapidly 
within the first 2 hrs compared to the analogous Tf-N formulations.  
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Nanoparticle Form
ulation 
 
 
m
PEG 
20Tf-N 
200Tf-N 
20Tf-C 
120Tf-C 
200Tf-C 
2Ab-N 
10Ab-N 
2Ab-C 
10Ab-C 
Nanoparticle Formulation 
m
PEG 
X 
  
  
  
  
  
  
  
  
  
20Tf-N 
<0.0001 
X 
  
  
  
  
  
  
  
  
200Tf-N 
<0.0001 
<0.0001 
X 
  
  
  
  
  
  
  
20Tf-C 
<0.0001 
0.590 
<0.0001 
X 
  
  
  
  
  
  
120Tf-C 
<0.0001 
<0.0001 
<0.0001 
0.0005 
X 
  
  
  
  
  
200Tf-C 
<0.0001 
<0.0001 
<0.0001 
<0.0001 
0.114 
X 
  
  
  
  
2Ab-N 
<0.0001 
<0.0001 
0.5344 
<0.0001 
<0.0001 
<0.0001 
X 
  
  
  
10Ab-N 
<0.0001 
<0.0001 
0.2342 
<0.0001 
<0.0001 
<0.0001 
0.999 
X 
  
  
2Ab-C 
<0.0001 
<0.0001 
0.0186 
<0.0001 
<0.0001 
<0.0001 
0.243 
0.2352 
X 
  
10Ab-C 
0.0008 
<0.0001 
0.0003 
<0.0001 
<0.0001 
<0.0001 
0.0095 
0.00014 
0.0026 
X 
  Table S2: P-values for all potential pairwise comparisons for in vivo quantitative analysis. Values were calculated using the W
ilcoxon 
rank-sum test.   
   
